Citations

Mayo Clinic

Showing 10 of 108572 citations.

Site-specific proteolysis of mini-F plasmid replication protein RepE destroys initiator function and generates an incompatibility substance
Kline, B C, Sandhu, Gurpreet S. , Eckloff, Bruce W., Aleff, Ross A.

Journal of Bacteriology | November 7, 2016 | Volume: 174 | Issue: 9 | Pages: 3004-3010

10.1128/jb.174.9.3004-3010.1992 | PMID 1569028 Get It

Plasmid F replication is controlled by a plasmid-specified Rep protein with both autorepressor and initiator functions. The mechanism by which these two functions of a Rep protein are balanced to achieve stable replication is unknown; however, we speculated in prior work that Rep protein modification could be involved. We report here that naturally proteolyzed F RepE protein has been detected and characterized. The processed molecule lost the first 17 N-terminal aminoacyl residues and initiator function but acquired increased specific DNA-binding affinity in the presence of Escherichia coli chromosomal DNA. When supplied in trans, the altered protein acts as an incompatibility substance and eliminates maintenance of F'lac. These findings indicate that protein processing has the potential to contribute to the overall control of DNA replication.
Biology of VO2max: looking under the physiology lamp
Lundby, Carsten , Montero, David , Joyner, Michael J. , Joyner, Michael J

Acta Physiologica | November 7, 2016 | Volume: 220 | Issue: 2 | Pages: 218-228

10.1111/apha.12827 | PMID 27888580 Get It

AbstractIn this review, we argue that several key features of maximal oxygen uptake (VO2max) should underpin discussions about the biological and reductionist determinants of its interindividual variability: (i) training‐induced increases in VO2max are largely facilitated by expansion of red blood cell volume and an associated improvement in stroke volume, which also adapts independent of changes in red blood cell volume. These general concepts are also informed by cross‐sectional studies in athletes that have very high values for VO2max. Therefore, (ii) variations in VO2max improvements with exercise training are also likely related to variations in these physiological determinants. (iii) All previously untrained individuals will respond to endurance exercise training in terms of improvements in VO2max provided the stimulus exceeds a certain volume and/or intensity. Thus, genetic analysis and/or reductionist studies performed to understand or predict such variations might focus specifically on DNA variants or other molecular phenomena of relevance to these physiological pathways.
Outcomes of atrial arrhythmia radiofrequency catheter ablation in patients with Ebstein’s anomaly
Hassan, Abdalla, Tan, Nicholas Y. , Aung, Htin , Connolly, Heidi M. , Hodge, David O. , Vargas, Emily , Cannon, Bryan C. , Packer, Douglas L. , Asirvatham, Samuel J. , Vargas, Emily R, McLeod, Christopher J. , Asirvatham, Samuel J

EP Europace | November 7, 2016 | Volume: 20 | Issue: 3 | Pages: 535-540

10.1093/europace/euw396 | PMID 28340054 Get It

Diagnosis of Acute Cellular Rejection and Antibody-Mediated Rejection on Lung Transplant Biopsies: A Perspective From Members of the Pulmonary Pathology Society
Roden, Anja C. , Aisner, Dara L. , Allen, Timothy Craig, Aubry, Marie Christine, Barrios, Roberto, Beasley, Mary Beth , Cagle, Philip T., Capelozzi, Vera Luíza , Đačić, Sanja , Ge, Yimin , Lantuéjoul, Sylvie , Miller, Ross A., Moreira, André , Raparia, Kirtee, Sholl, Lynette M. , Tsao, Ming‐Sound , Vivero, Marina , Yatabe, Yasushi , Yi, Eunhee S. , Hariri, Lida P. , Miller, Ross, Mino-Kenudson, Mari A. , Rekhtman, Natasha , Smith, Maxwell L.

Archives of Pathology & Laboratory Medicine | November 7, 2016 | Volume: 141 | Issue: 3 | Pages: 437-444

10.5858/arpa.2016-0459-sa | PMID 27819763 Get It

Context.— The diagnosis and grading of acute cellular and antibody-mediated rejection (AMR) in lung allograft biopsies is important because rejection can lead to acute graft dysfunction and/or failure and may contribute to chronic graft failure. While acute cellular rejection is well defined histologically, no reproducible specific features of AMR are currently identified. Therefore, a combination of clinical features, serology, histopathology, and immunologic findings is suggested for the diagnosis of AMR. Objective.— To describe the perspective of members of the Pulmonary Pathology Society (PPS) on the workup of lung allograft transbronchial biopsy and the diagnosis of acute cellular rejection and AMR in lung transplant. Data Sources.— Reports by the International Society for Heart and Lung Transplantation (ISHLT), experience of members of PPS who routinely review lung allograft biopsies, and search of literature database (PubMed). Conclusions.— Acute cellular rejection should be assessed and graded according to the 2007 working formulation of the ISHLT. As currently no specific features are known for AMR in lung allografts, the triple test (clinical allograft dysfunction, donor-specific antibodies, pathologic findings) should be used for its diagnosis. C4d staining might be performed when morphologic, clinical, and/or serologic features suggestive of AMR are identified.
Circular RNAs and their associations with breast cancer subtypes
Nair, Asha, Niu, Nifang, Tang, Xiaojia , Thompson, Kevin J. , Wang, Liewei , Kocher, Jean‐Pierre , Subramanian, Subbaya , Kalari, Krishna R. , Nair, Asha A, Thompson, Kevin J , Kalari, Krishna R , Tang, Xiaojia

Oncotarget | November 5, 2016 | Volume: 7 | Issue: 49 | Pages: 80967-80979

10.18632/oncotarget.13134 | PMID 27829232 Get It

Reply
Chaiteerakij, Roongruedee , Roberts, Lewis R. , Roberts, Lewis R , Choi, Jonggi , Chaiteerakij, Roongruedee

Hepatology | November 5, 2016 | Volume: 65 | Issue: 4 | Pages: 1422-1423

10.1002/hep.28922 | PMID 28032640 Get It

The unfolded protein response mediates fibrogenesis and collagen I secretion through regulating TANGO1 in mice
Maiers, Jessica L. , Kostallari, Enis , Mushref, Malek, deAssuncao, Thiago M., Li, Haiyang , Jalan‐Sakrikar, Nidhi , Cao, Sheng , Shah, Vijay H. , Malhi, Harmeet , Li, Haiyang, Huebert, Robert C. , Kostallari, Enis , Sakrikar, Nidhi Jalan

Hepatology | November 5, 2016 | Volume: 65 | Issue: 3 | Pages: 983-998

10.1002/hep.28921 | PMID 28039913 Get It

Fibrogenesis encompasses the deposition of matrix proteins, such as collagen I, by hepatic stellate cells (HSCs) that culminates in cirrhosis. Fibrogenic signals drive transcription of procollagen I, which enters the endoplasmic reticulum (ER), is trafficked through the secretory pathway, and released to generate extracellular matrix. Alternatively, disruption of procollagen I ER export could activate the unfolded protein response (UPR) and drive HSC apoptosis. Using a small interfering RNA screen, we identified Transport and Golgi organization 1 (TANGO1) as a potential participant in collagen I secretion. We investigated the role of TANGO1 in procollagen I secretion in HSCs and liver fibrogenesis. Depletion of TANGO1 in HSCs blocked collagen I secretion without affecting other matrix proteins. Disruption of secretion led to procollagen I retention within the ER, induction of the UPR, and HSC apoptosis. In wild‐type (WT) HSCs, both TANGO1 and the UPR were induced by transforming growth factor β (TGFβ). As the UPR up‐regulates proteins involved in secretion, we studied whether TANGO1 was a target of the UPR. We found that UPR signaling is responsible for up‐regulating TANGO1 in response to TGFβ, and this mechanism is mediated by the transcription factor X‐box binding protein 1 (XBP1). In vivo , murine and human cirrhotic tissue displayed increased TANGO1 messenger RNA levels. Finally, TANGO1 +/– mice displayed less hepatic fibrosis compared to WT mice in two separate murine models: CCl 4 and bile duct ligation. Conclusion : Loss of TANGO1 leads to procollagen I retention in the ER, which promotes UPR‐mediated HSC apoptosis. TANGO1 regulation during HSC activation occurs through a UPR‐dependent mechanism that requires the transcription factor, XBP1. Finally, TANGO1 is critical for fibrogenesis through mediating HSC homeostasis. The work reveals a unique role for TANGO1 and the UPR in facilitating collagen I secretion and fibrogenesis. (H epatology 2017;65:983‐998).
Celiac Disease and Risk of Henoch-Schonlein Purpura
Jarrick, Simon , Ludvigsson, Jonas F. , Murray, Joseph A. , Emilsson, Louise

Journal of Clinical Gastroenterology | November 5, 2016 | Volume: 52 | Issue: 2 | Pages: 141-145

10.1097/mcg.0000000000000750 | PMID 27820222 Get It

Background and Aims: A recent study found a 10-fold increased risk of celiac disease (CD) in individuals with Henoch-Schonlein purpura (HSP), but the confidence interval (CI) was wide. Methods: The retrospective cohort study of all patients with CD in Sweden, diagnosed through small intestinal biopsy from 1969 to 2008 (n=29,077). Each individual with CD was matched to up to 5 controls (n=144,433). Data on study participants were linked to diagnostic codes for HSP in the National Patient Registry. Through Cox regression we estimated hazard ratios for CD and later HSP. Through logistic regression we calculated odds ratios for HSP preceding CD. Results: During follow-up 19 individuals with CD and 99 controls developed HSP. This corresponded to a hazard ratio of 0.96 (95% CI, 0.59-1.56). Looking backward, we found no increased risk of earlier HSP in patients with CD (odds ratio=1.02; 95% CI, 0.60-1.72). Conclusions: In this study of more than 29,000 patients with CD, we found no increased risk of HSP before or after CD.
Atypical Notochordal Cell Tumors
Carter, Jodi M. , Wenger, Doris E. , Rose, Peter S. , Inwards, Carrie Y., Carter, Jodi

American Journal of Surgical Pathology | November 5, 2016 | Volume: 41 | Issue: 1 | Pages: 39-48

10.1097/pas.0000000000000766 | PMID 27819871 Get It

By the current WHO classification, benign notochordal cell tumor (BNCT) and chordoma comprise the entire spectrum of notochordal-derived tumors. They have defined radiologic and histologic criteria, and differ considerably in management and clinical outcome. Chordomas are malignant tumors; they show progressive, destructive growth and have the capacity for metastasis. In contrast, BNCT are benign and show limited intraosseous growth. Patients with BNCT can be managed with serial imaging or conservative excision, whereas patients with spinal/sacral chordomas typically undergo radical en bloc resection often with adjuvant therapy and significant morbidity. As such, the distinction between BNCT and chordoma is critically important. We have seen 4 unusual notochordal tumors with radiologic and/or histologic features that defy classification as either BNCT or chordoma. Cases occurred in 4 adults (53 to 83 y), and involved the lumbar spine (N=2) and sacrum (N=2). Three cases had subtle radiologic features of cortical permeation with minimal soft tissue extension. All 4 cases had the characteristic histologic features of BNCT; however, 2 cases also had focal myxoid change. Three patients were followed with serial imaging (follow-up range, 26 to 120 mo); 2 showed no disease progression and 1 had a 10-year cumulative interval growth of 3.7 mm. One patient underwent sacrectomy. The tumor was examined in toto and had the characteristic histologic features of BNCT, with the exception of minimal soft tissue extension. On the basis of these observations, we propose a provisional designation of atypical notochordal cell tumors (ANCT) be used for the subset of notochordal-derived tumors that fail to fulfill current diagnostic criteria for either BNCT or chordoma. We would argue that designating these atypical notochordal tumors as chordoma precipitates potentially overly aggressive surgical management. Patients with ANCT may be better managed by close observation and serial imaging. Additional studies with more cases and longer clinical follow-up should clarify the relationship of ANCT to BNCT and chordoma.
Current Status of Neuromuscular Reversal and Monitoring
Brull, Sorin J. , Kopman, Aaron F., Brull, Sorin J

Anesthesiology | November 5, 2016 | Volume: 126 | Issue: 1 | Pages: 173-190

10.1097/aln.0000000000001409 | PMID 27820709 Get It

Abstract Postoperative residual neuromuscular block has been recognized as a potential problem for decades, and it remains so today. Traditional pharmacologic antagonists (anticholinesterases) are ineffective in reversing profound and deep levels of neuromuscular block; at the opposite end of the recovery curve close to full recovery, anticholinesterases may induce paradoxical muscle weakness. The new selective relaxant-binding agent sugammadex can reverse any depth of block from aminosteroid (but not benzylisoquinolinium) relaxants; however, the effective dose to be administered should be chosen based on objective monitoring of the depth of neuromuscular block. To guide appropriate perioperative management, neuromuscular function assessment with a peripheral nerve stimulator is mandatory. Although in many settings, subjective (visual and tactile) evaluation of muscle responses is used, such evaluation has had limited success in preventing the occurrence of residual paralysis. Clinical evaluations of return of muscle strength (head lift and grip strength) or respiratory parameters (tidal volume and vital capacity) are equally insensitive at detecting neuromuscular weakness. Objective measurement (a train-of-four ratio greater than 0.90) is the only method to determine appropriate timing of tracheal extubation and ensure normal muscle function and patient safety.